We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.50 | 0.34% | 1,646.00 | 1,646.00 | 1,646.50 | 1,647.00 | 1,634.00 | 1,638.50 | 1,100,857 | 14:47:33 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.66 | 67.33B |
TIDMGSK
RNS Number : 4695H
GlaxoSmithKline PLC
12 March 2018
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') === ===================================================================== a) Name Ms E Walmsley === ======================== =========================================== b) Position/status Chief Executive Officer === ======================== =========================================== c) Initial notification/ Initial notification amendment === ======================== =========================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ===================================================================== a) Name GlaxoSmithKline plc === ======================== =========================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =========================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ===================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== =========================================== b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ======================== =========================================== c) Price(s) and Price(s) Volume(s) volume(s) ----------- ------------------------ GBP13.4317 10 (partnership shares) ----------- ------------------------ GBP13.4317 10 (matching shares) ----------- ------------------------ === ======================== =========================================== d) Aggregated information Aggregated volume Price 20 Ordinary Shares GBP13.4317 === ======================== =========================================== e) Date of the transaction 2018-03-09 === ======================== =========================================== f) Place of the London Stock Exchange (XLON) transaction === ======================== =========================================== 1. Details of PDMR/person closely associated with them ('PCA') === ===================================================================== a) Name Mr R G Connor === ======================== =========================================== b) Position/status President, Global Manufacturing & Supply === ======================== =========================================== c) Initial notification/ Initial notification amendment === ======================== =========================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ===================================================================== a) Name GlaxoSmithKline plc === ======================== =========================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =========================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ===================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== =========================================== b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ======================== =========================================== c) Price(s) and Price(s) Volume(s) volume(s) ----------- ------------------------ GBP13.4317 10 (partnership shares) ----------- ------------------------ GBP13.4317 10 (matching shares) ----------- ------------------------ === ======================== =========================================== d) Aggregated information Aggregated volume Price 20 Ordinary Shares GBP13.4317 === ======================== =========================================== e) Date of the transaction 2018-03-09 === ======================== =========================================== f) Place of the London Stock Exchange (XLON) transaction === ======================== =========================================== 1. Details of PDMR/person closely associated with them ('PCA') === ===================================================================== a) Name Mr S Dingemans === ======================== =========================================== b) Position/status Chief Financial Officer === ======================== =========================================== c) Initial notification/ Initial notification amendment === ======================== =========================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ===================================================================== a) Name GlaxoSmithKline plc === ======================== =========================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =========================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ===================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== =========================================== b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ======================== =========================================== c) Price(s) and Price(s) Volume(s) volume(s) ----------- ------------------------ GBP13.4317 10 (partnership shares) ----------- ------------------------ GBP13.4317 10 (matching shares) ----------- ------------------------ === ======================== =========================================== d) Aggregated information Aggregated volume Price 20 Ordinary Shares GBP13.4317 === ======================== =========================================== e) Date of the transaction 2018-03-09 === ======================== =========================================== f) Place of the London Stock Exchange (XLON) transaction === ======================== =========================================== 1. Details of PDMR/person closely associated with them ('PCA') === ===================================================================== a) Name Mr N Hirons === ======================== =========================================== b) Position/status SVP, Global Ethics & Compliance === ======================== =========================================== c) Initial notification/ Initial notification amendment === ======================== =========================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ===================================================================== a) Name GlaxoSmithKline plc === ======================== =========================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =========================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ===================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== =========================================== b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan. === ======================== =========================================== c) Price(s) and Price(s) Volume(s) volume(s) ----------- ------------------------ GBP13.4317 10 (partnership shares) ----------- ------------------------ GBP13.4317 10 (matching shares) ----------- ------------------------ === ======================== =========================================== d) Aggregated information Aggregated volume Price 20 Ordinary Shares GBP13.4317 === ======================== =========================================== e) Date of the transaction 2018-03-09 === ======================== =========================================== f) Place of the London Stock Exchange (XLON) transaction === ======================== =========================================== 1. Details of PDMR/person closely associated with them ('PCA') === ===================================================================== a) Name Mr L Miels === ======================== =========================================== b) Position/status President, Global Pharmaceuticals === ======================== =========================================== c) Initial notification/ Initial notification amendment === ======================== =========================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ===================================================================== a) Name GlaxoSmithKline plc === ======================== =========================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =========================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ===================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== =========================================== b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ======================== =========================================== c) Price(s) and Price(s) Volume(s) volume(s) ----------- ------------------------ GBP13.4317 10 (partnership shares) ----------- ------------------------ GBP13.4317 10 (matching shares) ----------- ------------------------ === ======================== =========================================== d) Aggregated information Aggregated volume Price 20 Ordinary Shares GBP13.4317 === ======================== =========================================== e) Date of the transaction 2018-03-09 === ======================== =========================================== f) Place of the London Stock Exchange (XLON) transaction === ======================== =========================================== 1. Details of PDMR/person closely associated with them ('PCA') === ===================================================================== a) Name Mr D S Redfern === ======================== =========================================== b) Position/status Chief Strategy Officer === ======================== =========================================== c) Initial notification/ Initial notification amendment === ======================== =========================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ===================================================================== a) Name GlaxoSmithKline plc === ======================== =========================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =========================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ===================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== =========================================== b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ======================== =========================================== c) Price(s) and Price(s) Volume(s) volume(s) ----------- ------------------------ GBP13.4317 10 (partnership shares) ----------- ------------------------ GBP13.4317 10 (matching shares) ----------- ------------------------ === ======================== =========================================== d) Aggregated information Aggregated volume Price 20 Ordinary Shares GBP13.4317 === ======================== =========================================== e) Date of the transaction 2018-03-09 === ======================== =========================================== f) Place of the London Stock Exchange (XLON) transaction === ======================== =========================================== 1. Details of PDMR/person closely associated with them ('PCA') === ===================================================================== a) Name Ms C Thomas === ======================== =========================================== b) Position/status SVP, Human Resources === ======================== =========================================== c) Initial notification/ Initial notification amendment === ======================== =========================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ===================================================================== a) Name GlaxoSmithKline plc === ======================== =========================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =========================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ===================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== =========================================== b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ======================== =========================================== c) Price(s) and Price(s) Volume(s) volume(s) ----------- ------------------------ GBP13.4317 10 (partnership shares) ----------- ------------------------ GBP13.4317 10 (matching shares) ----------- ------------------------ === ======================== =========================================== d) Aggregated information Aggregated volume Price 20 Ordinary Shares GBP13.4317 === ======================== =========================================== e) Date of the transaction 2018-03-09 === ======================== =========================================== f) Place of the London Stock Exchange (XLON) transaction === ======================== =========================================== 1. Details of PDMR/person closely associated with them ('PCA') === ===================================================================== a) Name Mr P C Thomson === ======================== =========================================== b) Position/status President, Global Affairs === ======================== =========================================== c) Initial notification/ Initial notification amendment === ======================== =========================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
=== ===================================================================== a) Name GlaxoSmithKline plc === ======================== =========================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =========================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ===================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== =========================================== b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ======================== =========================================== c) Price(s) and Price(s) Volume(s) volume(s) ----------- ----------------------- GBP13.4317 9 (partnership shares) ----------- ----------------------- GBP13.4317 9 (matching shares) ----------- ----------------------- === ======================== =========================================== d) Aggregated information Aggregated volume Price 18 Ordinary Shares GBP13.4317 === ======================== =========================================== e) Date of the transaction 2018-03-09 === ======================== =========================================== f) Place of the London Stock Exchange (XLON) transaction === ======================== =========================================== 1. Details of PDMR/person closely associated with them ('PCA') === ===================================================================== a) Name Dr P J T Vallance === ======================== =========================================== b) Position/status President, R&D === ======================== =========================================== c) Initial notification/ Initial notification amendment === ======================== =========================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ===================================================================== a) Name GlaxoSmithKline plc === ======================== =========================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =========================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ===================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== =========================================== b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ======================== =========================================== c) Price(s) and Price(s) Volume(s) volume(s) ----------- ----------------------- GBP13.4317 9 (partnership shares) ----------- ----------------------- GBP13.4317 9 (matching shares) ----------- ----------------------- === ======================== =========================================== d) Aggregated information Aggregated volume Price 18 Ordinary Shares GBP13.4317 === ======================== =========================================== e) Date of the transaction 2018-03-09 === ======================== =========================================== f) Place of the London Stock Exchange (XLON) transaction === ======================== =========================================== 1. Details of PDMR/person closely associated with them ('PCA') === ===================================================================== a) Name Mrs V A Whyte === ======================== =========================================== b) Position/status Company Secretary === ======================== =========================================== c) Initial notification/ Initial notification amendment === ======================== =========================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ===================================================================== a) Name GlaxoSmithKline plc === ======================== =========================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =========================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ===================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== =========================================== b) Nature of the Acquisition of Ordinary Shares under the transaction Company's Share Reward Plan. === ======================== =========================================== c) Price(s) and Price(s) Volume(s) volume(s) ----------- ------------------------ GBP13.4317 10 (partnership shares) ----------- ------------------------ GBP13.4317 10 (matching shares) ----------- ------------------------ === ======================== =========================================== d) Aggregated information Aggregated volume Price 20 Ordinary Shares GBP13.4317 === ======================== =========================================== e) Date of the transaction 2018-03-09 === ======================== =========================================== f) Place of the London Stock Exchange (XLON) transaction === ======================== ===========================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHQLLFFVXFLBBD
(END) Dow Jones Newswires
March 12, 2018 12:31 ET (16:31 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions